But the data presented at the Brussels meeting made it clear that something strange was happening: the therapeutic power of the drugs appeared to be steadily waning. A recent study showed an effect that was less than half of that documented in the first trials, in the early nineteen-nineties. Many researchers began to argue that the expensive pharmaceuticals weren’t any better than first-generation antipsychotics, which
Watch Streaming Broadcast Live:
LRN.fm
Live Chat
Telegram
Share this page with your friends
on your favorite social network:
Loading...